Coherus Oncology CHRS 深 沪
等待开盘 11-12 09:30:00 美东时间
0.6103
-0.031
-4.77%
华盛通- 最 高0.6501
- 今 开0.6501
- 成交量 95.13万股
- 最 低 0.6069
- 昨 收 0.6409
- 总市值 9431.47万
- 52周最高 2.6158
- 市盈率 静 --
- 换手率 0.62%
- 52周最低 0.6046
- 委 比 -88.06%
- 总股本 1.55亿
- 历史最高 38.10
- 量 比 1.65
- 振 幅 6.74%
- 历史最低 0.6046
- 每 手 1
- 风险率 0.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国银行维持英伟达"超配"评级！但目标价从315美元降至300美元
今日重点评级关注：花旗：维持Faeth Therapeutics"买入"评级，目标价从55美元升至60美元；HC Wainwright & Co.：维持Ocular Therapeutix"买入"评级，目标价从25美元升至28美元
11-11 10:50
Coherus Oncology shares are trading lower after the company reported worse-than-expected Q3 sales results.
Coherus Oncology shares are trading lower after the company reported worse-than-expected Q3 sales results.
11-11 02:05
Guggenheim Maintains Buy on Coherus Oncology, Lowers Price Target to $8
Guggenheim analyst Paul Jeng maintains Coherus Oncology (NASDAQ:CHRS) with a Buy and lowers the price target from $10 to $8.
11-10 21:56
Coherus Oncology 2026财年第3季度营收1427.4万美元，同比增长23.36%
最新财报显示，Coherus Oncology 2026财年第3季度实现： 营业收入：1427.4万美元 同比：增长23.36% 净利润：-3933.4万美元...
11-10 17:00
Coherus Oncology收涨6.18%，成交额180.26万美元
11月10日，Coherus Oncology（CHRS）收涨6.18%，报0.82美元，成交额180.26万美元，市值1.26亿美元。 行情数据 • 开盘价...
11-10 07:56
Coherus BioSciences Q3 Adj. EPS $(0.20) Beats $(0.22) Estimate, Sales $14.274M Miss $16.005M Estimate
Coherus BioSciences (NASDAQ:CHRS) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 39.39 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $14.274 mil...
11-10 05:14
Coherus Oncology收跌9.72%，成交额203.35万美元
11月3日，Coherus Oncology（CHRS）收跌9.72%，报0.75美元，成交额203.35万美元，市值1.16亿美元。 行情数据 • 开盘价：...
11-03 07:55
美股大行评级 | 潜在涨幅1112.12%！Canaccord Genuity上调Wave Life Sciences目标价至44美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences"买入"评级，目标价从42美元升至44美元；Canaccord Genuity：维持Pharming Group"买入"评级，目标价从38美元升至41美元
10-30 12:30
Coherus Biosciences reports promising interim oncology data
Coherus Biosciences ( ($CHRS) ) just unveiled an update. On October 28, 2026, C...
10-29 20:27
Coherus to Participate in Upcoming Investor Conferences
Coherus Oncology announced its participation in two upcoming investor conferences: the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, 2026, and the Jefferies Global Healthcare Conference in London on November 16, 2026. Presentations will be available via webcast on the company's website, with replays accessible for 30 days. Investors can request one-on-one meetings with management through their respective bank re...
10-27 13:30
